A detailed history of Invenio Wealth Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Invenio Wealth Partners LLC holds 4,098 shares of ABBV stock, worth $685,390. This represents 0.4% of its overall portfolio holdings.

Number of Shares
4,098
Previous 4,800 14.63%
Holding current value
$685,390
Previous $744 Million 0.32%
% of portfolio
0.4%
Previous 0.54%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$159.82 - $182.1 $112,193 - $127,834
-702 Reduced 14.63%
4,098 $746 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $5,091 - $5,733
37 Added 0.78%
4,800 $744 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $35,534 - $41,136
-266 Reduced 5.29%
4,763 $710 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $666,392 - $829,282
5,029 New
5,029 $678 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Invenio Wealth Partners LLC Portfolio

Follow Invenio Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenio Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invenio Wealth Partners LLC with notifications on news.